Loading the session
Loading the session
Loading instrument
$109.98
+0.53%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:21 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 3 Nov 2026 close of $109.40 was 5.1% above its 50-day average ($104.06) and 7.7% above its 200-day average ($101.57). It has closed above the 200-day for 9 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 16 Sep 2026, 34 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
1 month: +9.3% (SPY −2.6%, XLV +9.9%). 3 months: +3.7% (SPY −2.2%, XLV +13.5%). 1 year: −11.7% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ABT, SPY and XLV · as of 3 Nov 2026
Closed at $109.40 on 3 Nov 2026: 17.1% below the 52-week high of $132.03 (18 Nov 2025) and 33.5% above the low of $81.97 (11 May 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
17.4M shares were sold short at the 15 Oct 2026 settlement, 1.0% of the 1.73B shares outstanding; covering them would take 1.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 3 Nov 2026 close
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
July 16, 2026
+10.71%January 22, 2026
−10.04%July 17, 2025
−8.52%